Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-44,800
Closed -$2.37M – 175
2015
Q4
$2.37M Hold
44,800
– – 1.41% 10
2015
Q3
$2.21M Hold
44,800
– – 1.43% 12
2015
Q2
$2.55M Hold
44,800
– – 1.37% 11
2015
Q1
$2.58M Hold
44,800
– – 1.28% 11
2014
Q4
$2.54M Buy
44,800
+4,500
+11% +$263K 1.33% 8
2014
Q3
$2.39M Hold
40,300
– – 1.33% 8
2014
Q2
$2.33M Hold
40,300
– – 1.5% 8
2014
Q1
$2.29M Hold
40,300
– – 1.06% 15
2013
Q4
$2.02M Hold
40,300
– – 0.95% 25
2013
Q3
$1.92M Hold
40,300
– – 1.23% 15
2013
Q2
$1.87M Hold
40,300
– – 1.25% 15

Other funds holding MRK

Winmill & Co's MRK Position: Q1 2016 in Review

Winmill & Co sold out of Merck (MRK) in Q1 2016, closing a stake of 44,800 shares — an estimated $2.37M sold.

Winmill & Co first reported a position in MRK in Q2 2013 and held it in 11 quarters. The position peaked at $2.58M in Q1 2015. 1,745 funds tracked by Wall St. Rank hold MRK as of Q1 2016.

  • Winmill & Co reported no remaining Merck position as of Q1 2016 after selling out during the quarter.
  • Winmill & Co sold 44,800 Merck shares in Q1 2016, an estimated $2.37M.
  • Winmill & Co first reported a position in Merck in Q2 2013 and held it in 11 quarters.
  • Winmill & Co's Merck position peaked at $2.58M in Q1 2015.
  • 1,745 funds tracked by Wall St. Rank held Merck as of Q1 2016.

Based on Winmill & Co's 13F filing for Q1 2016, filed 28 Apr 2016.